GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: AMY-109 | H1009/L395-F1974m [2]
                                 
                                                         
                            
                            
                            
                                Compound class: 
                                                            Antibody
                                 
                                
                                    
                                        Comment: AMY109 is a long-acting monoclonal antibody that blocks IL-8 recycling [4]. It was designed to reduce levels of IL-8 in endometriosis lesions, in which excessive IL-8 has been identified as a driving factor in promoting inflammation and fibrosis [1,3,5]. AMY109 is proposed as a potential disease-modifying treatment for endometriosis. 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    AMY109 is engineered to bind IL-8 in a pH-dependent manner. In the acidic conditions within the endosome, the antibody-IL-8 mmune complex dissociates; the free antibody is re-cycled and the IL-8 is trafficked to the lysosome for degradation.  | 
                                    
| Bioactivity Comments | 
| AMY109 binds to cynoIL-8 with an affinity (Kd) of 0.38 nM (pKd 9.42) [4]. In vitro AMY109 inhibits both the recruitment of neutrophils to human endometriosis-derived cells, and neutrophil production of monocyte chemoattractant protein-1 [4]. | 
| Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
                                                                        
                                                                         
  | 
                                                                ||||||||||||||||||||||||||||||||||